Effect of metformin on patients with impaired glucose tolerance
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Aims To evaluate the effect of metformin on glucose metabolism, insulin sensitivity and rate of conversion diabetes in people with impaired glucose tolerance (IGT). Methods Seventy subjects with IGT were randomized under double‐blind conditions to receive either placebo (n = 37) or metformin (n = 33) at a dosage of 250 mg three times daily for a duration of 12 months. Glycaemic control, plasma insulin and other biochemical indexes were assessed before and after 3, 6 and 12 months. Results At 12 months the conversion rate to diabetes was 16.2% in the placebo group compared to 3.0% for the metformin group (P = 0.011). Of subjects treated with metformin for 12 months, 84.9% became normoglycaemic compared to 51.4% of those receiving the placebo. Significant improvements in fasting glucose, glucose tolerance and insulin sensitivity were found at 12 months and at intermediate clinic assessments. Conclusions Metformin can improve glucose metabolism in IGT patients and may be a treatment option in their management of IGT subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults
King, H., Rewers, M., & Who Ad Hoc Diabetes Reporting Group (1993) · Diabetes Care · doi:10.2337/diacare.16.1.157 · Cited by 886
Cited by
Gerstein, H. C., Santaguida, P., Raina, P., Morrison, K. M., Balion, C., Hunt, D., Yazdi, H., & Booker, L. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.05.004 · Cited by 575
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
“62) (Figure 3).(33,44,55-73) Insulin sensitizers (metformin, rosiglitazone, and pioglitazone) achieved an RR reduction of 53% (RR, 0.”
BackgroundBarry, E., Roberts, S., Oke, J., Vijayaraghavan, S., Normansell, R., & Greenhalgh, T. (2017) · BMJ · doi:10.1136/bmj.i6538 · Cited by 330
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
Meta-analysis: metformin treatment in persons at risk for diabetes mellitus
Salpeter, S. R., Buckley, N. S., Kahn, J. A., & Salpeter, E. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.09.016 · Cited by 248
Metadata
- Authors
- Li, C. L., Pan, C. Y., Lu, J. M., Zhu, Y., Wang, J. H., Deng, X. X., Xia, F. C., Wang, H. Z., & Wang, H. Y.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 16
- Issue
- 6
- Pages
- 477-481
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2066039558
- Cited by
- 97
- References
- 3
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of metformin on patients with impaired glucose tolerance. https://app.cochat.ai/papers/10.1046/j.1464-5491.1999.00090.x
- The paper
- Li, C. L., Pan, C. Y., Lu, J. M., Zhu, Y., Wang, J. H., Deng, X. X., Xia, F. C., Wang, H. Z., & Wang, H. Y. (1999). Effect of metformin on patients with impaired glucose tolerance. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.1999.00090.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.